NCI and AppliedVR have formed a collaboration to evaluate whether virtual reality can address the underlying anxiety often experienced by many patients with terminal cancer.
As the Galleri test is advancing toward becoming the first multi-cancer detection test to secure FDA approval, cancer care providers are coming up with strategies for using these tests responsibly.
